Fideicomiso Irrevocable F/2061 Fhipo
BNZIF
$0.46
-$0.08-15.03%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 6.20M | 8.17M | 6.78M | 21.59M | 9.90M |
| Total Revenue | 6.20M | 8.17M | 6.78M | 21.59M | 9.90M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.20M | 8.17M | 6.78M | 21.59M | 9.90M |
| SG&A Expenses | 5.09M | 5.54M | 4.97M | 5.47M | 5.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.27M | 103.80K | -2.92M | 14.33M | -5.18M |
| Total Operating Expenses | 11.36M | 5.64M | 2.05M | 19.79M | 663.50K |
| Operating Income | -5.16M | 2.53M | 4.73M | 1.80M | 9.24M |
| Income Before Tax | -5.16M | 2.53M | 4.73M | 2.42M | 9.24M |
| Income Tax Expenses | 103.40K | 77.50K | 16.90K | -190.20K | 45.00K |
| Earnings from Continuing Operations | -5.26M | 2.45M | 4.71M | 2.61M | 9.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.26M | 2.45M | 4.71M | 2.61M | 9.19M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
| Normalized Basic EPS | -0.01 | 0.00 | -- | 0.00 | 0.03 |
| EPS Diluted | -0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
| Normalized Diluted EPS | -0.01 | 0.00 | -- | 0.00 | 0.03 |
| Average Basic Shares Outstanding | 373.35M | 373.35M | -- | 373.35M | 227.19M |
| Average Diluted Shares Outstanding | 373.35M | 373.35M | 373.35M | 373.35M | 227.19M |
| Dividend Per Share | -- | 0.02 | 0.02 | 0.01 | 0.02 |
| Payout Ratio | -135.50% | 274.92% | 51.64% | 315.68% | 79.16% |